In patients with type 2 diabetes, pioglitazone, glucagon-like peptide-1 receptor agonists, and sodium glucose cotransporter 2 inhibitors are recommended to improve liver fibrosis [34]. The gene discussed is GLP1R; the disease is Hepatic fibrosis.